Early Treatment With Alglucosidase Alfa Prolongs Long-Term Survival of Infants With Pompe Disease
暂无分享,去创建一个
J. Clancy | H. Mandel | N. Leslie | C. Morgan | S. Richards | P. Kishnani | D. Corzo | M. Beck | G. Morin | T. O'Meara | M. Bauer | D. Gruskin | R. Parini | M. Jokic | A. V. D. Ploeg | E. Tsao | Chen-en Tsai | Brian W H Tsai | A. T. Ploeg
[1] A. Rosenberg,et al. Elimination of antibodies to recombinant enzyme in Pompe's disease. , 2009, The New England journal of medicine.
[2] B. Byrne,et al. Clinical outcomes after long-term treatment with alglucosidase alfa in infants and children with advanced Pompe disease , 2009, Genetics in Medicine.
[3] D. Koeberl,et al. Enhanced response to enzyme replacement therapy in Pompe disease after the induction of immune tolerance. , 2007, American journal of human genetics.
[4] Yuan-Tsong Chen,et al. Glycogen storage disease types I and II: Treatment updates , 2007, Journal of Inherited Metabolic Disease.
[5] B. Byrne,et al. Recombinant human acid α-glucosidase , 2007, Neurology.
[6] H. Mandel,et al. Longer Survival by Enzyme Replacement Therapy Unmasks the Underrecognition of Otoneurologic Involvement in Infantile-Onset Pompe Disease , 2007 .
[7] B. Byrne,et al. Recombinant human acid [alpha]-glucosidase: major clinical benefits in infantile-onset Pompe disease. , 2007, Neurology.
[8] G. Herman,et al. Chinese hamster ovary cell-derived recombinant human acid alpha-glucosidase in infantile-onset Pompe disease. , 2006, The Journal of pediatrics.
[9] Wuh-Liang Hwu,et al. A retrospective, multinational, multicenter study on the natural history of infantile-onset Pompe disease. , 2006, The Journal of pediatrics.
[10] T. Voit,et al. Safety and efficacy of recombinant acid alpha-glucosidase (rhGAA) in patients with classical infantile Pompe disease: results of a phase II clinical trial , 2005, Neuromuscular Disorders.
[11] R. Howell,et al. Pompe disease in infants and children. , 2004, The Journal of pediatrics.
[12] W. Hop,et al. Long-Term Intravenous Treatment of Pompe Disease With Recombinant Human -Glucosidase From Milk , 2004 .
[13] J. Smeitink,et al. Enzyme therapy for Pompe disease with recombinant human α-glucosidase from rabbit milk , 2001, Journal of Inherited Metabolic Disease.
[14] W. Hop,et al. Long-term intravenous treatment of Pompe disease with recombinant human alpha-glucosidase from milk. , 2004, Pediatrics.
[15] W. Hop,et al. The natural course of infantile Pompe's disease: 20 original cases compared with 133 cases from the literature. , 2003, Pediatrics.
[16] J. Smeitink,et al. Enzyme therapy for pompe disease with recombinant human alpha-glucosidase from rabbit milk. , 2001, Journal of inherited metabolic disease.
[17] J. Charrow,et al. Recombinant human acid α-glucosidase enzyme therapy for infantile glycogen storage disease type II: Results of a phase I/II clinical trial , 2001, Genetics in Medicine.
[18] A. Amalfitano,et al. Towards a molecular therapy for glycogen storage disease type II (Pompe disease). , 2000, Molecular medicine today.
[19] Carole Hurran,et al. Motor Assessment of the Developing Infant , 1995 .
[20] T. Choudhury,et al. Glycogen storage disease (type-III). , 1991, Indian pediatrics.
[21] David R. Cox,et al. Regression models and life tables (with discussion , 1972 .
[22] E. Kaplan,et al. Nonparametric Estimation from Incomplete Observations , 1958 .